Question 1

What is the catalog number for Tissue FFPE Sections, Prostate?

Accepted Answer

The catalog number for Tissue FFPE Sections, Prostate is CS708136.

Question 2

What sizes are available for Tissue FFPE Sections, Prostate?

Accepted Answer

Tissue FFPE Sections, Prostate is available in the following size(s): 5x 5 µm.

Question 3

Is Tissue FFPE Sections, Prostate in stock?

Accepted Answer

Tissue FFPE Sections, Prostate is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Where can I find the safety data sheet (SDS/MSDS) for Tissue FFPE Sections, Prostate?

Accepted Answer

The safety data sheet for Tissue FFPE Sections, Prostate is available here: https://cdn.origene.com/sds/cs708136.pdf.

Question 5

What is Tissue FFPE Sections, Prostate used for?

Accepted Answer

Tissue Sections (5x5um), FFPE; Prostate; Hyperplasia of prostate

Question 6

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 7

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 8

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Tissue FFPE Sections, Prostate

Product Specifications

Stability

Storage Conditions

Frequently Asked Questions

Explore Other Products

Tissue FFPE Sections, Lung

Carburetor Ultrasonic BULC-603

Polystyrene C4 NH₂

Human TUBB8 activation kit by CRISPRa

LZTS1 / FEZ1 Rabbit Polyclonal Antibody

FITC Anti-Mouse CD335/NKp46 Antibody[29A1.4]